MoneyWorks4Me

Medicamen Biotech informs about disclosure

18 Dec 2021 Evaluate
Medicamen Biotech has informed that it enclosed the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, received by the company from Growel Remedies for sale of equity share.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..